Sonia Adams, MD
Urogynecology and Reconstructive Pelvic Surgery · Brighton, MANPI 1730308974
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Coloplast at 50.9% of the total. Reporting peaked in 2019 at $1,059 and has fallen 89.2% since, to $115 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in MA, where the typical reported total is $2,944.
Across 26 payments — averaging $85.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$1K
- Boston Scientific$207
- Caldera Medical, Inc$185
- Axonics, Inc.$167
- Medtronic$154
- AbbVie$136
- plus $248 from 4 others
What the payments were for
- Travel & lodging$73633%
- Food & beverage$1,29858%
- Education$2009%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 9 | $1,138 |
| Boston Scientific | 3 | $207 |
| Caldera Medical, Inc | 1 | $185 |
| Axonics, Inc. | 1 | $167 |
| Medtronic | 2 | $154 |
| AbbVie(2 entities) | 2 | $136 |
| Intuitive Surgical | 1 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $57 |
| Abbott | 2 | $48 |
| Johnson & Johnson | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,235 in reported general payments places this provider in the 45th percentile of 35 urogynecology and reconstructive pelvic surgery providers in Massachusetts.
See all urogynecology and reconstructive pelvic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 107 | $70,098 |
| GemtesaVibegron | 11 | $7,012 |
| Estradiol | 49 | $3,884 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $167 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Brighton
- Diego IllanesMilford$277K
- Peter RosenblattCambridge$223K
- Eman ElkadryCambridge$130K
- Amos AdelowoWorcester$30K
- Lori JonesBoston$22K
- William WinkelmanCambridge$16K
- Vikas MerchiaBrockton$15K
- John Al JamalBoston$15K
- Youngwu KimBoston$14K
- Jyot SainiWellesley$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.